William Owen
Pediatric Hematology-Oncology · Norfolk, VANPI 1306885876
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $54,323 of the $68,205 with a category attached, or 79.6%. 16 manufacturers reported payments, led by Novartis at 56.4% of the total. Reporting peaked in 2020 at $20,503 and has fallen 96.2% since, to $770 in 2025. Among pediatric hematology-oncology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 96 payments — averaging $710.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$38K
- Global Blood Therapeutics, Inc.$20K
- Pfizer$8K
- Agios Pharmaceuticals, Inc.$295
- Novo Nordisk$246
- Sanofi$202
- plus $1K from 10 others
Across 2 payments — averaging $7500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$10K
- National Marrow Donor Program$6K
What the payments were for
- Consulting fees$1,9253%
- Speaking & faculty fees$54,32380%
- Travel & lodging$8,54713%
- Food & beverage$3,4115%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 34 | $38,444 |
| Global Blood Therapeutics, Inc. | 30 | $19,919 |
| Pfizer | 11 | $8,085 |
| Agios Pharmaceuticals, Inc. | 3 | $295 |
| Novo Nordisk | 2 | $246 |
| Sanofi | 2 | $202 |
| Sobi, Inc | 2 | $190 |
| Genetix Biotherapeutics Inc | 1 | $162 |
| Servier Pharmaceuticals LLC | 3 | $158 |
| AstraZeneca | 1 | $126 |
| Amgen | 1 | $121 |
| QOL Medical, LLC | 1 | $90 |
| Genentech USA, Inc. | 2 | $66 |
| Adaptive Biotechnologies Corporation | 1 | $64 |
| RARE Disease Therapeutics, Inc. | 1 | $24 |
| Shire North American Group Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$68,205 in reported general payments places this provider in the 95th percentile of 31 pediatric hematology-oncology providers in Virginia.
See all pediatric hematology-oncology providers in Virginia →
Other pediatric hematology-oncology in Norfolk
- Eric LoweNorfolk$12K
- Melissa MarkNorfolk$3K
- Wilson FileNorfolk$161
- Katherine WatsonNorfolk$143
- Linda PegramNorfolk$61
- Eric WernerNorfolk$47
- Daniel LeeCharlottesville$42K
- Zhihong WangRichmond$23K
- India SislerRichmond$15K
- Elizabeth KriegerRichmond$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.